The efficacy of vigorous-intensity exercise as an aid to smoking cessation in adults with elevated anxiety sensitivity: study protocol for a randomized controlled trial

J. Smits, Jasper A.; Zvolensky, Michael J.; Rosenfield, David; Marcus, Bess H.; Church, Timothy S.; Frierson, Georita M.; Powers, Mark B.; Otto, Michael W.; Davis, Michelle L.; DeBoer, Lindsey B.; Briceno, Nicole F.
January 2012
Trials;2012, Vol. 13 Issue 1, p207
Academic Journal
Background: Although cigarette smoking is a leading cause of death and disability in the United States (US), over 40 million adults in the US currently smoke. Quitting smoking is particularly difficult for smokers with certain types of psychological vulnerability. Researchers have frequently called attention to the relation between smoking and anxiety-related states and disorders, and evidence suggests that panic and related anxiety vulnerability factors, specifically anxiety sensitivity (AS or fear of somatic arousal), negatively impact cessation. Accordingly, there is merit to targeting AS among smokers to improve cessation outcome. Aerobic exercise has emerged as a promising aid for smoking cessation for this high-risk (for relapse) group because exercise can effectively reduce AS and other factors predicting smoking relapse (for example, withdrawal, depressed mood, anxiety), and it has shown initial efficacy for smoking cessation. The current manuscript presents the rationale, study design and procedures, and design considerations of the Smoking Termination Enhancement Project (STEP). Methods: STEP is a randomized clinical trial that compares a vigorous-intensity exercise intervention to a health and wellness education intervention as an aid for smoking cessation in adults with elevated AS. One hundred and fifty eligible participants will receive standard treatment (ST) for smoking cessation that includes cognitive behavioral therapy (CBT) and nicotine replacement therapy (NRT). In addition, participants will be randomly assigned to either an exercise intervention (ST+EX) or a health and wellness education intervention (ST+CTRL). Participants in both arms will meet 3 times a week for 15 weeks, receiving CBT once a week for the first 7 weeks, and 3 supervised exercise or health and wellness education sessions (depending on randomization) per week for the full 15-week intervention. Participants will be asked to set a quit date for 6 weeks after the baseline visit, and smoking cessation outcomes as well as putative mediator variables will be measured up to 6 months following the quit date. Discussion: The primary objective of STEP is to evaluate whether vigorous-intensity exercise can aid smoking cessation in anxiety vulnerable adults. If effective, the use of vigorous-intensity exercise as a component of smoking cessation interventions would have a significant public health impact. Specifically, in addition to improving smoking cessation treatment outcome, exercise is expected to offer benefits to overall health, which may be particularly important for smokers. The study is also designed to test putative mediators of the intervention effects and therefore has the potential to advance the understanding of exercise-anxiety-smoking relations and guide future research on this topic. Clinical trials registry: ClinicalTrials.gov, NCT01065506, http://clinicaltrials.gov/ct2/show/NCT01065506


Related Articles

  • Evidence for global health. Jha, Prabhat; Lavery, James V. // CMAJ: Canadian Medical Association Journal;5/25/2004, Vol. 170 Issue 11, p1687 

    Discusses research being done on the paucity of randomized controlled trials (RCT) in addressing major global diseases. Reference to a study by P.A. Rochon et al., published in the May 25, 2004 issue of the "Canadian Medical Association Journal"; Lack of evidence from RCT being directed to...

  • Cholecystokinin C-45T polymorphism and smoking cessation in women. Ton, Thanh G.; Rossing, Mary Anne; Bowen, Deborah J.; Wilkerson, Hui-Wen; Farin, Federico M. // Nicotine & Tobacco Research;Jan2007, Vol. 9 Issue 1, p147 

    In view of the effect of cholecystokinin (CCK) on dopaminergic neurons in the mesolimbic “reward” pathway of the brain, its gene has been a focus in studies of dopamine-related conditions and behaviors, including smoking. We assessed the association between the CCK C-45T polymorphism...

  • Menthol cigarettes and health risks in Lung Health Study data. Murray, Robert P.; Connett, John E.; Skeans, Melissa A.; Tashkin, Donald P. // Nicotine & Tobacco Research;Jan2007, Vol. 9 Issue 1, p101 

    Whether menthol cigarettes confer a higher risk of death than plain cigarettes is not known. The Lung Health Study (LHS) enrolled 5,887 adult smokers in a clinical trial of smoking cessation and ipratropium in the prevention of chronic obstructive pulmonary disease. LHS participants have been...

  • Development of Procedures for Early Screening of Smoking Cessation Medications in Humans. Perkins, KA; Lerman, C; Stitzer, ML; Fonte, CA; Briski, JL; Scott, JA; Chengappa, KNR // Clinical Pharmacology & Therapeutics;Aug2008, Vol. 84 Issue 2, p216 

    Candidate medications for smoking cessation may be screened more efficiently if initial evaluations in humans combine the practical advantages of laboratory studies with the clinical validity of clinical trials, such as by increasing participants' “quit motivation” during brief...

  • WHO seeks system for tracking global clinical trials. Check, Erika // Nature;11/11/2004, Vol. 432 Issue 7014, p137 

    The article presents a report on a system for tracking global clinical trials. The World Health Organization (WHO) hopes to earn international support next week for a far-reaching plan to set up a global tracking system for clinical trials. These measures are intended to reduce the duplication...

  • Texting an unlikely tool in smoking cessation.  // Drugs & Alcohol Today;Dec2005, Vol. 5 Issue 4, p8 

    Focuses on the outcome of a clinical trial in New Zealand involving the use of text messaging in smoking cessation programs. Background on the text messages received by young smokers participating in the study; Comparison of quit rates between two groups of smokers; Implications of the results...

  • Community Intervention Trial for Smoking Cessation (COMMIT): I. Cohort Results from a Four-Year Community Intervention.  // American Journal of Public Health;Feb1995, Vol. 85 Issue 2, p183 

    Objectives. The primary hypothesis of COMMIT (Community Intervention Trial for Smoking Cessation) was that a community-level, multichannel, 4-year intervention would increase quit rates among cigarette smokers, with heavy smokers (≥25 cigarettes per day) of priority. Methods. One community...

  • Rationale, design and conduct of a comprehensive evaluation of a school-based peer-led anti-smoking intervention in the UK: the ASSIST cluster randomised trial [ISRCTN55572965]. Starkey, Fenella; Moore, Laurence; Campbell, Rona; Sidaway, Mark; Bloor, Michael // BMC Public Health;2005, Vol. 5 Issue 1, p43 

    Background: To date, no school-based intervention has been proven to be effective in preventing adolescent smoking, despite continuing concern about smoking levels amongst young people in the United Kingdom. Although formal teacher-led smoking prevention interventions are considered unlikely to...

  • Clinician advice, an interactive computer program, and motivational counselling increased smoking cessation in teens. Hollis, J. F.; Polen, M. R.; Whitlock, E. P.; Lancaster, Tim // Evidence Based Medicine;Oct2005, Vol. 10 Issue 5, p144 

    The article discusses whether an intervention of brief clinician advice during routine medical visits, an interactive computer program, and brief motivational counseling reduce smoking in adolescent smokers and non-smokers over the long term. A randomized controlled trial had been conducted...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics